DDInter114 DDInter1180
Arbutamine, administered through a closed-loop, computer-controlled drug-delivery system, is indicated to elicit acute cardiovascular responses, similar to those produced by exercise, in order to aid in diagnosing the presence or absence of coronary artery disease in patients who cannot exercise adequately.
Methscopolamine is a quaternary ammonium derivative of scopolamine and antagonist at muscarininc (mACh) receptors. Methscopolamine bromide is the most common form of the active ingredient in oral pharmaceutical products. The oral tablets are used as an adjunct therapy for the treatment of peptic ulcer and is shown to be effective in decreasing the rate of recurrence of peptic ulcers as well as preventing complications.
Arbutamine {u} (Compound) resembles {v} (Compound) Isoprenaline
Arbutamine {u} (Compound) resembles {v} (Compound) Hexoprenaline
Arbutamine {u} (Compound) binds {v} (Gene) ADRB2
Arbutamine {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Dicyclomine
Arbutamine {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Mepenzolate
Arbutamine {u} may lead to a major life threatening interaction when taken with {v} Lidocaine
Arbutamine {u} may lead to a major life threatening interaction when taken with {v} Doxepin
Arbutamine (Compound) resembles Isoprenaline (Compound)
Arbutamine (Compound) resembles Hexoprenaline (Compound)
Arbutamine (Compound) binds ADRB2 (Gene)
Arbutamine may cause a moderate interaction that could exacerbate diseases when taken with Dicyclomine
Arbutamine may cause a moderate interaction that could exacerbate diseases when taken with Mepenzolate
Arbutamine may lead to a major life threatening interaction when taken with Lidocaine
Arbutamine may lead to a major life threatening interaction when taken with Doxepin